Aennitis技术保证14.5M欧元用于在生物生产方面商业推广coustatofluidic技术。 Aenitis Technologies secures €14.5M for commercial expansion of acoustofluidic technology in bioproduction.

Anitis Technology已经从欧洲创新理事会基金、 " Quadrivium I " 和 " Mifani Invest " 获得大量资金,共计1 450万欧元。 Aenitis Technologies has secured significant funding from the European Innovation Council Fund, Quadrivium I, and Mifani Invest, totaling €14.5 million. 这项投资将推动其声流体技术的商业推出和全球扩张, 为生物制造业提供可扩展和精确的细胞处理解决方案. This investment will drive the commercial launch and global expansion of its acoustofluidic technology, which offers scalable and precise cell processing solutions for the bioproduction industry. 这些资金还将支持其商品交易所专用产品MitisTM的最后开发阶段,并在关键市场建立分销渠道。 The funds will also support the final development stages of its CE-marked product, Mitis™, and establish distribution channels in key markets.